Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > adrenocorticosteroids > Flashcards

adrenocorticosteroids Flashcards

0
Q

describe the hormonal steroids..

A
  1. glucocorticoids - effects on intermediary metabolism and immune function
  2. mineralocorticoids - principally salt-retaining activity
  3. steroids c androgenic and estrogenic activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

describe the layers of adrenal glands..

A

capsule
adrenal cortex
zona glomerulosa - mineralocorticoids, mainly aldosterone
zona fasciculata - glucocoricoids, mainly cortisol
zona reticularis - androgens
adrenal medulla - chromaffin cells secrete Epi and NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

glucocorticoid agonists?

A 
prednisone
hydrocortisone
dexamethasone
beclomethasone
triamcinolone
methylprednisolone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

minderalocorticoid agonists?

A

aldosterone

fludrocortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

glucocorticoid antagonists?

A

mifepristone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

mineralocorticoid antagonists?

A

spironolactone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

drugs that cause hormonal synthesis inhibition?

A

ketoconazole
aminoglutethimide
metyrapone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe cortisol (hydrocortisone)

A

circadian rhythm and stress stimulate hypothalamus to release CRH -> act on the anterior pituitary to release ACTH -> act on the adrenal cortex -> release cortisol -> tissue responses (physiological/metabolic effects)

cortisol has negative feedback to the hypothalamus and anterior pituitary.

secretion and synthesis tightly regulated by CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cortisol (hydrocortisone)

MOA?

A
  • effects mediated by widely distributed glucocorticoid receptors.
  • steroid-receptor complex enters the nucleus and interacts c promoters of (and regulates the transcription of) target genes
  • produce tissue-specific responses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cortisol (hydrocortisone)

Metabolic effects?

A
  • stimulates and is required for gluconeogenesis & glycogen synthesis (which maintains hepatic glycogen avail) in fasting state
  • -> increase serum glucose levels (thus leading to stimulation of insulin release) & inhibiting uptake by muscle cells.
  • stimulates lipolysis (leading to fat deposition and redistribution & increased release of fatty acids & glycerol)
  • stimulates protein catabolism & release of amino acids

NET result: maintenance of an adequate glucose supply to brain (most apparent in fasting state)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cortisol (hydrocortisone)

Catabolic effects?

A
  • in addition to protein catabolism, cortisol also has effects in lymphoid and connective tissue, muscle, peripheral fat and skin (wasting occurs at high conc).
  • catabolic effects on bone = osteoporosis
  • in children = growth retardation
    Both are major limitations in long term tx c glucocorticoids.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cortisol (hydrocortisone)

Immunosuppressive effects?

A

effects on leukocytes:

  • increased neutrophils (increased influx into blood & decreased migration from blood vessels)
  • decreased lymphocytes (T and B cells), monocytes, eosinophils and basophils (movement from vascular bed to lymphoid tissue)

vasoconstriction due possibly to suppression of mast cell degranulation
- decreased histamine release and capillary permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cortisol (hydrocortisone)

Anti-inflammatory effects?

A
  • inhibit PLA2 (through induction & activation of annexin I) which blocks arachidonic acid release (major precursor for PG)
  • cyclooxygenase-2 synthesis is reduced (through inhibition of NF-kappB)
  • induction of MAPK phophatase I (inhibits MAPK activated proinflammatory signaling pathways).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cortisol (hydrocortisone)

other effects?

A

CNS: behavioral changes (insomnia, euphoria -> depression)

Increased ICP: large doses

Suppression of release of ACTH, GH, TSH, LH: chronic use

Peptic ulcers: stimulation of gastric acid. Suppression of immune response to H. pylori?

increase platelets & RBCs

Renal function: impaired c cortisol deficiency

Devel of fetal lungs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cortisol (hydrocortisone)

Pharmacokinetics?

A

short duration of action
diffuses poorly across skin (unless inflamed)
diffuses well across mucous membranes
some salt-retaining effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

prednisone, methylprednisolone, dexamethasone, beclometahsone, triamcinolone

PK?

A

prednisone = prodrug (rapidly converted to active prednisolone)

Beclomethasone = short t1/2, penetrates airway mucosa (low systemic toxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

prednisone, methylprednisolone, dexamethasone, beclometahsone, triamcinolone

Routes of Administration?

A

orall = all

IM = triamcinolone

IV,IM = dexamethasone, hydrocortisone, methylprednisolone, prednisolone

Aerosol = beclomethasone, triamcinolone

Topical = beclomethasone, dexamethasone, hydrocortisone, triamcinolone

17
Q

Mineralocorticoids

MOA?

A
  • bind to mineralocorticoid receptor
  • drug-receptor complex acts in similar fashion to glucorticoid drug-receptor complex
  • major effect of activation of aldosterone receptor:
  • — increased expression of Na/K ATPase
  • — increased expression of ENaC
18
Q

Mineralocorticoids

Major effects?

A

natural mineralocorticoid = aldosterone
salt-retaining hormones.

Under control and regulated of CRH, ACTH, and renin-angiotensin system.
Help to control body’s water vol & electrolyte concntrations (Na & K)
- promote Na reabsorption from renal tubule
- promote K and H excretion.

19
Q

tx for Addison’s disease?

A

Addison’s disease

  • characterized by weakness, fatigue, weight loss, hypotension, hyperpigmentation, inability to maintain blood glucose levels fasting.
  • tx: daily hydrocortisone (increase dose during stress) + fludrocortisone.

DO NOT adminster long-acting glucocorticopids or ones lacking salt-retaining effects.

20
Q

tx that is associated c life-threatening shock, infxn, trauma?

A

tx: start immediately
Large amounts of parenteral hydrocortisone + correction of fluid & electrolyte abnlities.
Can adminster salt-retaining hormone once hydrocortisone levels are reduced (~5days)

21
Q

describe Congenital Adrenal Hyperplasia…

A

defect in cortisol synthesis: CRH production by hypothalamus or corticotropin production by pituitary -> decreased steroid levels -> increase ACTH and hyperplasia in adrenal gland -> increased amounts of cortisol precursors that are diverted to the androgen pathway.

MOST common defect in adrenal hyperplasia = 21-hydroxylase activity

22
Q

TX for Congenital Adrenal Hyperplasia?

A

glucocorticoid admin. leads to suppression of ACTH.

tx initially as an acute adrenal crisis
once stabilized: oral hydrocortisone or prednisone + fludrocortisone

Fetus can be protected in high-risk pregnancies by dexamethasone admin. to mother.

23
Q

Tx for Cushing syndrome?

A

usually result of B/L adrenal hyperplasia secondary to ACTH-secreting pituitary adenoma.
Manifestations associated c chronic presence of excessive glucocorticoids

TX: surgical removal of tumor, irradiation of pituitary tumor, or resection of one of both adrenals.
pts must receive high doses of cortisol before and after surgery (dose has to be slowly decreased to prevent withdrawal)

24
Q

TX for Aldosteronism?

A

primary aldosteronism usually results from excessive production by adrenal adenoma (can be from malignant tumor)
sx: result from renal loss of K (hypokalemia, alkalosis, & elevation of serum Na)

DX and TX:
spironolactone

25
Q

describe using dexamethasone suppression test…

A

Cushing’s syndrome: dexamethasone suppresses cortisol release in individuals c pituitary-dependent Cushing’s syndrome (not released from adrenal tumors)

Depressive psychiatric states.

26
Q

TX in Lung maturation in fetus?

A

IM dexamethasone.

fetal lung maturation is regulated by cortisol secretion. If premature delivery is expected, tx of the mother c large doses of glucocorticoids reduces incidence of respiratory distress syndrome.

27
Q

Tx of non-adrenal disorders with synthetic corticosteroids?

A
  1. numerous immunological inflammatory conditions: asthma, collagen vascular disorders (RA), ocular diseases (uveitis, optic neuritis, exopthalmos)
  2. allergic rxns (contact dermatitis, urticaria)
  3. Hodgkin’s lymphoma (prednisone)
  4. cerebral edema (dexamethasone)
  5. chemotherapy-induced vomiting
  6. hematologic disorders (anemia, leukemia)
  7. organ transplants (prev of rejection)
  8. renal disorders (nephrotic syndrome)
  9. hypercalcemia
  10. mountain sickness
  11. inflammatory bowel disease
  12. idiopathic orthostatic hypotension (fludrocortisone)
28
Q

what to consider when tx c corticosteroid?

A
  • balance benefits c adverse effects.
  • short-term use = few serious a.e
  • try to tx c short-intermediate acting steroids as much as possible
  • long-term used produces predictable toxicity based on their physiological effects.
29
Q

corticosteroids a.e’s?

A
  • metabolic effects (cushing’s syndrome manifestations)
  • peptic ulcers
  • clinical findings of certain disorders (particularly bacterial/mycotic infxns) may be masked by steroid use
  • myopathy (part. c long-acting steroids)
  • nausea, dizziness, weight loss
  • CNS (euphoria, psychosis, depression)
  • increased intraocular pressure (glaucoma)
  • posterior subcapsular cataracts
  • Na & fluid retention, loss of K
  • Growth retardation (children)
  • adrenal suppression
30
Q

how to minimize toxicities in corticosteroid uses?

A
  • local application
  • use as low a dose as possible
  • taper dose soon after achieving tx goal
  • alternate-day therapy
  • adm. pts c adrenal insufficiency ‘stress dose’ during serious illness or prior surgery
  • prevent K loss c supplementation
  • prev effects on bone by Ca and vitD supplements
31
Q

corticosteroid contraindications?

A
  • peptic ulcers
  • heart disease or HTN c heart failure
  • TB, VZV infxn
  • psychoses
  • diabetes
  • osteoporosis
  • glaucoma
32
Q

corticosteroid withdrawal complications?

A
  • abrupt c/drawal can be a serious problem (acute adrenal insufficiency syndrome can result)
  • dose must be tapered according to individual
  • monitor closely
33
Q

Spironolactone

clinical applications?

A
  • aldosteronism (dx and tx)
  • hirsutism in women (acts as androgen antagonist)
  • diuretic
34
Q

spironolactone

Adverse effects?

A
  • hyperkalemia
  • cardiac arrythmia
  • menstrual abnormalities
  • gynecomastia
  • sedation
  • HA
  • GI disturbances
  • Skin rashes
35
Q

aminoglutethimide

MOA?

A

blocks conversion of cholesterol to prenenolone -> reduces synthesis of all hormonally active steroids

36
Q

aminoglutethimide

Clinical application?

A

adrenal cancer (+hydrocortisone or dexamethasone)

37
Q

Ketoconazole

MOA?

A

potent & non-selective inhibitor or adrenal & gonadal steroid synthesis

38
Q

ketoconazole

CLinical applications?

A

Cushing’s syndrome

Prostate cancer

39
Q

Metyrapone

MOA?

A

Relatively selective inhibitor of steroid 11-hydroxylation (interferes c cortisol & corticosterone synthesis)

40
Q

metyrapone

Clinical applications?

A

tests of adrenal function

tx of pregnant women c cushing’s

41
Q

metyrapone

Adverse Effects?

A

salt & water retention
Hirsutism
transient dizziness
GI disturbances

Pharmacology (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions